申请人:G. D. Searle & Co.
公开号:US04791133A1
公开(公告)日:1988-12-13
This invention relates to leukotriene B.sub.4 antagonists having the structure ##STR1## and the pharmaceutically acceptable addition salts thereof; wherein R.sup.1 is lower alkyl having 1-10 carbon atoms; or lower alkenyl or alkynyl having 2-10 carbon atoms; or lower alkadienyl having 3-10 carbon atoms; or lower alkadiynyl or alkenynyl having 4-10 carbon atoms; wherein R.sup.2 and R.sup.3 are the same or different and represent hydrogen or lower alkyl having 1-6 carbon atoms; wherein X is CH.dbd.CH, S, or O; wherein Y is CH.dbd.CH or C.tbd.C; wherein Z is OR.sup.4 or NR.sup.5 R.sup.6, and wherein R.sup.4 represent H, lower alkyl having 1-6 carbon atoms, or a pharmaceutically acceptable cation, and wherein R.sup.5 and R.sup.6 act independently and represent H or lower alkyl having 1-6 carbon atoms, or R.sup.5 and R.sup.6 may act together with N to form a cycloamine of the formula: ##STR2## wherein q is an integer from 2-5; wherein m and n are the same or different and either 1 or 0; and wherein p is an integer from 1 to 5.
本发明涉及结构式为##STR1##及其药学上可接受的加盐物的白三烯B.sub.4拮抗剂;其中,R.sup.1是具有1-10个碳原子的低烷基;或具有2-10个碳原子的低烯基或炔基;或具有3-10个碳原子的低二烯基;或具有4-10个碳原子的低二炔基或烯炔基;其中,R.sup.2和R.sup.3相同或不同,代表氢或具有1-6个碳原子的低烷基;其中,X是CH.dbd.CH,S或O;其中,Y是CH.dbd.CH或C.tbd.C;其中,Z是OR.sup.4或NR.sup.5 R.sup.6,其中,R.sup.4代表H,具有1-6个碳原子的低烷基或药学上可接受的阳离子,而R.sup.5和R.sup.6独立地代表H或具有1-6个碳原子的低烷基,或者R.sup.5和R.sup.6可以与N一起形成以下公式的环胺:##STR2##其中,q是2-5的整数;m和n相同或不同,为1或0;p是1到5的整数。